Introduction: Cerebrospinal fluid biomarkers increasingly inform the causes of dementia and may provide objective markers of disease progression. There is a need to decipher participant and procedural factors that promote participation in studies incorporating longitudinal biomarker measures. Methods: Participant and procedural factors associated with participation in longitudinal biomarker studies were determined in individuals enrolled in studies of memory and aging at the Knight Alzheimer Disease Research Center (Saint Louis, MO, USA). Results: Complications were encountered following 331 of 1484 lumbar punctures (22.3%; LPs), affecting 280 of 929 participants (30.1%); in >95% complications were minor. Three hundred fifteen of 679 eligible participants (46.4%) completed multiple LPs. Younger age (odds ratio [OR] 2.08 per decade [95% confidence interval (CI) 1.61-2.94]), normal cognition (OR 21.4 [2.85-160.1]), and the absence of heart disease (OR 2.0 [1.01-3.85]) or seizures at study entry identified participants with increased odds of completing three or more LPs. Discussion: Factors influencing participation may be leveraged to improve recruitment and retention within observational and therapeutic studies requiring serial LPs.
the <5% of participants who require an autologous blood patch for the treatment of post-dural puncture headache. [15] [16] [17] [18] [19] [20] Prior research in this area has shown that fearfulness of LP is reduced in participants who have previously completed a successful LP, 14 suggesting that these participants should be more willing to participate in subsequent LPs. However, retention within studies requiring serial LPs remains challenging.
There is a need to promote participant enrollment and engagement within research studies requiring serial LPs, yet the factors that influence longitudinal participation are largely unknown. Recognizing this, we evaluated the participant and procedural factors that asso- 
METHODS

Standard protocol approvals, registrations, and patient consents
Clinical assessments and research lumbar punctures
Beginning in 2004, newly enrolled research participants agreed in principle to undergo an LP for research purposes at study entry and every 3 years thereafter. Exceptions were made for African American participants, with the intent to improve representation within research, irrespective of opportunities to measure CSF biomarkers.
Prior to undergoing an LP, participants were evaluated by experienced clinicians using semi-structured interviews with both the participant and a knowledgeable collateral source, and a detailed neurologic examination of the participant. 21 
Data analysis
Data availability
Study data are available to qualified investigators upon approval of a resource request by the Knight ADRC Data Request Committee (https://knightadrc.wustl.edu/research/resourcerequest.htm). at study entry were not asked to complete subsequent LPs. 
RESULTS
Participant demographics
Lumbar puncture complications
Participation in serial lumbar punctures
Rates of participation in serial LPs among eligible participants declined following the first and second LPs before plateauing (Figure 1 ). 15, 17, 18, 20 In addition, it is unknown whether rapid access to blood patches-a unique feature of this study-influenced 
TA B L E 3 Association between participant and procedural factors and post-LP complications
CONCLUSIONS
Younger, cognitively normal participants without known heart disease or seizure disorder at study entry were more likely to participate in studies requiring serial CSF sampling. Prior history of LP complications did not influence participation in LP studies when controlling for the effect of other variables. Knowledge of the participant and procedural specific factors that influence participation in studies requiring serial CSF sampling may be leveraged to promote recruitment and retention within studies requiring serial LPs. 
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